Article
Hybrid contact lens receives FDA nod
Carlsbad, CA—The FDA has given SynergEyes Inc. approval to market SynergEyes A hybrid contact lenses to correct hyperopic, myopic, and astigmatic errors, including presbyopia.
The lens features a high-Dk rigid gas-permeable (RGP) center with a hydrophilic, non-ionic soft skirt and will correct ametropia from –20 to 20 D with up to 6 D of astigmatism. A patent-pending HyperBond junction technology provides a strong interface between the soft and rigid portions of the lens, the company said.
SynergEyes, which plans a fall launch, said the lens offers the visual acuity of an RGP lens and the all-day comfort of a soft lens. It plans to expand its hybrid lens line to include lenses specifically for patients with keratoconus, presbyopia, and post-surgical vision correction needs.
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
